ResMed

Tweet this page
<
2018
2019
2020
2021
2022
2023
2024
2025
>
Registration as it was on 11 Feb 2025
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

25,000€ - 49,999€

Financial year: Jul 2023 - Jun 2024

Lobbyists (Full time equivalent)

0.5 Fte (2)

Lobbyists with EP accreditation

2

High-level Commission meetings

3

Lobbying Costs over the years

  • Info

    ResMed   (RMD)

    EU Transparency Register

    209143033529-94 First registered on 21 Dec 2018

    Goals / Remit

    ResMed (NYSE: RMD, ASX: RMD) manufactures digital health technologies and cloud-connected medical devices transform care for people with sleep apnoea, insomnia, COPD, and other chronic diseases. Our comprehensive out-of-hospital software platforms support the professionals and caregivers who help people stay healthy in the home or care setting of their choice. By enabling better care, we improve quality of life, reduce the impact of chronic disease, and lower costs for consumers and healthcare systems in more than 140 countries.

    Main EU files targeted

    • Implementation of Regulation (EU) 2017/745 of the European Parliament and of the Council of 5 April 2017 on medical devices (MDR)
    • Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard to the processing of personal data and on the free movement of such data (GDPR)
    • European Health Data Space proposal COM(2022) 197 final
    • European Strategy for Data COM(2020) 66 final
    • Regulation (EU) 2024/1689 of the European Parliament and of the Council of 13 June 2024 laying down harmonised rules on artificial intelligence (AI Act)
    • EU Green Deal
    • Regulation (EU) 2023/2854 of the European Parliament and of the Council of 13 December 2023 on harmonised rules on fair access to and use of data and amending Regulation (EU) 2017/2394 and Directive (EU) 2020/1828 (Data Act)

    Address

    Head Office
    9001 Spectrum Center Blvd
    San Diego 92123
    UNITED STATES
    EU Office
    Bolwerklaan 21 Box 8
    Brussels 1210
    BELGIUM

    Website

    https://www.resmed.com/

  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    25%2

    Lobbyists (Full time equivalent)

    0.5

    Lobbyists with EP accreditation

    All Lobbyists with EP accreditation over time

    2 accreditations were / are live (in bold) for the selected state of 16 Mar 2025

    Name Start date End Date
    Francesca RISSO 20 Nov 2024 20 Nov 2025
    Justyna VANDENBOSCH 08 Oct 2024 08 Oct 2025
    Justyna VANDENBOSCH 25 Jan 2024 04 Oct 2024
    Francesca RISSO 24 Jan 2024 04 Oct 2024
    Justyna VANDENBOSCH 25 Jan 2023 25 Jan 2024
    Francesca RISSO 22 Oct 2022 21 Oct 2023

    Complementary Information

    None declared

    Person in charge of EU relations

    Data not provided by Register Secretariat due to GDPR

    Person with legal responsibility

    Data not provided by Register Secretariat due to GDPR

  • Categories

    Category

    Companies & groups

  • Networking

    Affiliation

    MedTech Europe: https://www.medtecheurope.org/
    DIGITALEUROPE: https://www.digitaleurope.org/
    European Business Summit https://ebsummits.eu/
    EGN https://be.egn.com/

    Member organisations

    None declared

  • Financial Data

    Interests represented

    Promotes their own interests or the collective interests of their members

    Closed financial year

    Jul 2023 - Jun 2024

    Lobbying costs for closed financial year

    25,000€ - 49,999€

    Major contributions in closed year

    None declared

    Intermediaries for closed year

    NameAmount
    fti consulting belgium 25,000€ - 49,999€

    Intermediaries for current year

    Name
    fti consulting

    Closed year Costs

    25,000€ - 49,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None declared

    Groups (European Parliament)

    N/A

    Communication activities

    - Engaging with European Commission officials including Commissioners, cabinet members and services in DGs such as DG Grow, DG Connect and DG Sante; with MEPS and secretariats on committees such as IMCO, SANT, ENVI and ITRE; and with officials in the Working Party on Pharmaceuticals and Medical Devices in the Council of Ministers and Permanent Representations
    - Attending public hearings and events hosted in the EU institutions related to healthcare and digital policy

    Other activities

    None declared

  • Meetings

    Meetings

    3 meetings found. Download meetings

    The list below covers meetings with Commissioners/Cabinet members/Directors-general (high-level) Commission meetings published December 2014 to December 2024, and the meetings of Commissioners/Cabinet members/Directors-general and officials holding "management functions" in the Commission published since 1 January 2025. Other lobby meetings with lower-level staff may well have taken place, but the Commission doesn't proactively publish information about these meetings. All information below comes from the Commission and not from the registrant.

    1 July 2024: We have noted that some meetings are appearing in duplicate, ie. some meetings seem to be listed twice. This seems to be because the Commission changes some element of a meeting data after the meeting has first been listed, which causes LobbyFacts to register it as a new meeting. We are investigating further.

Download this datacard